Toronto Dominion Bank Lowers Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Toronto Dominion Bank reduced its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 50.3% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 38,692 shares of the company’s stock after selling 39,110 shares during the period. Toronto Dominion Bank’s holdings in Henry Schein were worth $2,922,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. McGlone Suttner Wealth Management Inc. bought a new position in shares of Henry Schein in the fourth quarter worth approximately $39,000. Mather Group LLC. purchased a new stake in shares of Henry Schein during the 1st quarter valued at $97,000. Palisade Asset Management LLC purchased a new stake in shares of Henry Schein during the 1st quarter valued at $113,000. Benjamin F. Edwards & Company Inc. lifted its holdings in shares of Henry Schein by 37.8% during the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 1,516 shares of the company’s stock worth $114,000 after acquiring an additional 416 shares during the last quarter. Finally, Covestor Ltd grew its position in Henry Schein by 12.8% in the first quarter. Covestor Ltd now owns 1,511 shares of the company’s stock worth $114,000 after acquiring an additional 171 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Price Performance

Shares of Henry Schein stock opened at $72.31 on Friday. The company’s fifty day simple moving average is $68.08 and its two-hundred day simple moving average is $71.88. Henry Schein, Inc. has a 12-month low of $60.01 and a 12-month high of $82.63. The firm has a market cap of $9.26 billion, a PE ratio of 24.43, a price-to-earnings-growth ratio of 1.78 and a beta of 0.87. The company has a quick ratio of 1.02, a current ratio of 1.75 and a debt-to-equity ratio of 0.47.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $1.01 by $0.09. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. The company had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.21 billion. During the same period in the prior year, the business posted $1.21 earnings per share. Henry Schein’s revenue for the quarter was up 3.7% on a year-over-year basis. As a group, equities analysts expect that Henry Schein, Inc. will post 5.16 EPS for the current year.

Analysts Set New Price Targets

A number of research firms have weighed in on HSIC. Evercore ISI lowered their price target on Henry Schein from $75.00 to $72.00 and set an “in-line” rating on the stock in a research report on Tuesday, July 9th. Robert W. Baird upgraded Henry Schein from a “neutral” rating to an “outperform” rating and boosted their target price for the stock from $81.00 to $92.00 in a research report on Monday, July 22nd. Piper Sandler reaffirmed an “overweight” rating and issued a $86.00 target price on shares of Henry Schein in a research note on Friday, June 21st. Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. Finally, UBS Group cut their price objective on shares of Henry Schein from $82.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, May 8th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Henry Schein presently has an average rating of “Moderate Buy” and a consensus price target of $81.67.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.